^
BIOMARKER:

TNFRSF8 negative

i
Other names: TNFRSF8, TNF Receptor Superfamily Member 8, Tumor Necrosis Factor Receptor Superfamily Member 8, Lymphocyte Activation Antigen CD30, CD30L Receptor, Ki-1 Antigen, D1S166E, CD30, Tumor Necrosis Factor Receptor Superfamily, Member 8, Cytokine Receptor CD30, CD30 Antigen, TNFRSF8, Ki-1
Entrez ID:
Related biomarkers:
Phase 1
Washington University School of Medicine
Active, not recruiting
Last update posted :
08/03/2021
Initiation :
09/18/2014
Primary completion :
06/09/2017
Completion :
12/31/2021
TNFRSF8
|
TNFRSF8 positive • TNFRSF8 expression • TNFRSF8 negative
|
Revlimid (lenalidomide) • Adcetris (brentuximab vedotin)
Phase 1
UNC Lineberger Comprehensive Cancer Center
Recruiting
Last update posted :
07/07/2021
Initiation :
07/15/2016
Primary completion :
01/01/2022
Completion :
01/01/2037
ALK • TNFRSF8
|
ALK negative • TNFRSF8 expression • TNFRSF8 negative
Phase 2
Memorial Sloan Kettering Cancer Center
Recruiting
Last update posted :
05/12/2021
Initiation :
07/03/2018
Primary completion :
07/01/2023
Completion :
07/01/2023
TNFRSF8
|
TNFRSF8 negative
|
Adcetris (brentuximab vedotin)
Phase 1
Fox Chase Cancer Center
Recruiting
Last update posted :
03/26/2021
Initiation :
02/22/2017
Primary completion :
12/01/2021
Completion :
07/01/2022
TNFRSF8 • CD4
|
TNFRSF8 positive • TNFRSF8 negative
|
Adcetris (brentuximab vedotin) • Istodax (romidepsin)